Skip to main content
. 2020 Mar 17;2(1):123–126. doi: 10.1016/j.jaccao.2019.12.001

Figure 1.

Figure 1

Echocardiography Demonstrating Rapid Progression of Aortic Valve Stenosis in a Patient With CML Treated With Nilotinib

Aortic valve maximum velocity (Vmax) increased from 2.8 m/s at treatment initiation to 4.2 m/s after 3 years of nilotinib treatment. CML = chronic myeloid leukemia.